Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD

被引:24
作者
Li, Haiqing [1 ]
Zeng, Zixiong [1 ]
Cheng, Juan [1 ]
Hu, Guoping [1 ]
Li, Yuqun [1 ]
Wei, Liping [1 ]
Zhou, Yumin [2 ]
Ran, Pixin [2 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 3, Dept Resp Med, Guangzhou, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
AECOPD; NT-proBNP; mortality; prognosis; OBSTRUCTIVE PULMONARY-DISEASE; BRAIN NATRIURETIC PEPTIDE; VENTRICULAR DYSFUNCTION; CARDIAC DYSFUNCTION; HEART-FAILURE; MANAGEMENT; LIFE;
D O I
10.2147/COPD.S231808
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective: The association between N-terminal pro B-type natriuretic peptide (NT-proBNP) concentrations and in-hospital and 1-year mortality in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) patients is largely unknown. Our objective was to explore the usefulness of NT-proBNP concentrations in AECOPD patients as a prognostic marker for in-hospital and 1-year mortality. Methods: NT-proBNP levels were measured in patients upon admission and laboratory and clinical data were also recorded. The cut-point for the NT-proBNP concentration level for in-hospital death was obtained using the receiver operating characteristic (ROC) curve. Univariate and multivariate logistic regression and Cox regression were used in the analyses of factors of in-hospital and 1-year mortality. Results: A total of 429 patients were enrolled. Twenty-nine patients died during hospitalization and 59 patients died during the 1-year follow-up. Patients who died in-hospital compared with those in-hospital survivors were older (80.14 +/- 6.56 vs 75.93 +/- 9.45 years, p=0.003), had a higher percentage of congestive heart failure (65.52% vs 33.75%, p<0.001), had higher NT-proBNP levels (5767.00 (1372.50-12,887.00) vs 236.25 (80.03-1074.75) ng/L, p<0.001), higher neutrophil counts (10.52 +/- 5.82 vs 7.70 +/- 4.31, p=0.016), higher D-dimer levels (1231.62 +/- 1921.29 vs 490.11 +/- 830.19, p=0.048), higher blood urea nitrogen levels (9.91 +/- 6.33 vs 6.51 +/- 4.01 mmol/L, p=0.001), a lower body mass index (19.49 +/- 3.57 vs 22.19 +/- 4.76, p=0.003), and higher hemoglobin levels (122.34 +/- 25.36 vs 130.57 +/- 19.63, p=0.034). The area under the ROC curve (AUC) for NT-proBNP concentration was 0.88 (95% confidence interval [CI], 0.84-0.93). NT-proBNP concentrations >= 551.35 ng/L were an independent prognostic factor for both in-hospital and 1-year mortality after adjustment for relative risk (RR) (RR=29.54, 95% CI 3.04-286.63, p=0.004 for the multivariate logistic regression analysis) and hazard ratio (HR) (HR=4.47, 95% CI, 2.38-8.41, p<0.001 for the multivariate cox regression analysis). Conclusion: NT-proBNP was a strong and independent predictor of in-hospital and 1-year mortality in AECOPD patients.
引用
收藏
页码:57 / 67
页数:11
相关论文
共 25 条
[1]   Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction [J].
Adrish, Muhammad ;
Nannaka, Varalaxmi Bhavani ;
Cano, Edison J. ;
Bajantri, Bharat ;
Diaz-Fuentes, Gilda .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 :1183-1189
[2]   Chronic obstructive pulmonary disease and cardiovascular disease [J].
Bhatt, Surya P. ;
Dransfield, Mark T. .
TRANSLATIONAL RESEARCH, 2013, 162 (04) :237-251
[3]   Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD [J].
Chang, Catherina L. ;
Robinson, Scott C. ;
Mills, Graham D. ;
Sullivan, Glenda D. ;
Karalus, Noel C. ;
McLachlan, John D. ;
Hancox, Robert J. .
THORAX, 2011, 66 (09) :764-768
[4]   Plasma N-terminal Pro-brain Natriuretic Peptide: A Prognostic Marker in Patients with Chronic Obstructive Pulmonary Disease [J].
Chi, Su Young ;
Kim, Eun Young ;
Ban, Hee Jung ;
Oh, In Jae ;
Kwon, Yong Soo ;
Kim, Kyu Sik ;
Kim, Yu Il ;
Kim, Young Chul ;
Lim, Sung Chul .
LUNG, 2012, 190 (03) :271-276
[5]   Hypoxic Pulmonary Vasoconstriction From Molecular Mechanisms to Medicine [J].
Dunham-Snary, Kimberly J. ;
Wu, Danchen ;
Sykes, Edward A. ;
Thakrar, Amar ;
Parlow, Leah R. G. ;
Mewburn, Jeffrey D. ;
Parlow, Joel L. ;
Archer, Stephen L. .
CHEST, 2017, 151 (01) :181-192
[6]   Complex chronic comorbidities of COPD [J].
Fabbri, L. M. ;
Luppi, F. ;
Beghe, B. ;
Rabe, K. F. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (01) :204-212
[7]   Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patients [J].
Hildebrandt, Per ;
Collinson, Paul O. .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (3A) :25A-28A
[8]   NT-proBNP independently predicts long term mortality after acute exacerbation of COPD - a prospective cohort study [J].
Hoiseth, Arne Didrik ;
Omland, Torbjorn ;
Hagve, Tor-Arne ;
Brekke, Pal H. ;
Soyseth, Vidar .
RESPIRATORY RESEARCH, 2012, 13
[9]   Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD [J].
Hu, Guoping ;
Wu, Yankui ;
Zhou, Yumin ;
Wu, Zelong ;
Wei, Liping ;
Li, Yuqun ;
Peng, Gongyong ;
Liang, Weiqiang ;
Ran, Pixin .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 :2729-2736
[10]   Cardiac dysfunction and N-terminal pro-B-type natriuretic peptide in exacerbations of chronic obstructive pulmonary disease [J].
Lee, M. H. S. ;
Chang, C. L. ;
Davies, A. R. ;
Davis, M. ;
Hancox, R. J. .
INTERNAL MEDICINE JOURNAL, 2013, 43 (05) :595-598